Abstract:Background: Psoriasis is an inflammatory skin disease associated with multiple comorbidities and substantially diminishes patients' quality of life. The gut microbiome has become a hot topic in psoriasis as it has been shown to affect both allergy and autoimmunity diseases in recent studies. Our objective was to identify differences in the fecal microbial composition of patients with psoriasis compared with healthy individuals to unravel the microbiota profiling in this autoimmune disease. Results: We collected fecal samples from 30 psoriasis patients and 30 healthy controls, sequenced them by 16S rRNA high-throughput sequencing, and identified the gut microbial composition using bioinformatic analyses including Quantitative Insights into Microbial Ecology (QIIME) and Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt). Our results showed that different relative abundance of certain bacterial taxa between psoriasis patients and healthy individuals, including Faecalibacterium and Megamonas, were increased in patients with psoriasis. It's also implicated that many cytokines act as main effect molecules in the pathology of psoriasis. We selected the inflammation-related indicators that were abnormal in psoriasis patients and found the microbiome variations were associated with the level of them, especially interleukin-2 receptor showed a positive relationship with Phascolarctobacterium and a negative relationship with the Dialister. The relative abundance of Phascolarctobacterium and Dialister can be regard as predictors of psoriasis activity. The correlation analysis based on microbiota and Inflammation-related indicators showed that microbiota dysbiosis might induce an abnormal immune response in psoriasis. Conclusions: We concluded that the gut microbiome composition in psoriasis patients has been altered markedly and provides evidence to understand the relationship between gut microbiota and psoriasis. More mechanistic experiments are needed to determine whether the differences observed in gut microbiota are the cause or consequences of psoriasis and whether the relationship between gut microbiota and cytokines was involved.

ANTIGENIC AND RELATED BIOCHEMICAL PROPERTIES OF LISTERIA MONOCYTOGENES I

[Intestinal necrosis as presentation form of mesenteric cyst].

Gut–Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis

Gut microbiota and psoriasis: pathogenesis, targeted therapy, and future directions

Skin and Gut Microbiome in Psoriasis: Gaining Insight Into the Pathophysiology of It and Finding Novel Therapeutic Strategies

Interferon β2 as a promoter of growth and differentiation of B cells.

Iterative algorithm to improve the separating power on coded-aperture images.

Probiotics in the Therapeutic Arsenal of Dermatologists

[The eosinophil and Entamoeba histolytica. II. Testicular amebic lesions produced in eosinophilic rats].

The role of Allium cepa on aluminum-induced reproductive dysfunction in experimental male rat models

Impact of Gut Bacterial Metabolites on Psoriasis and Psoriatic Arthritis: Current Status and Future Perspectives

Interplay Between Skin Microbiota Dysbiosis and the Host Immune System in Psoriasis: Potential Pathogenesis

Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patients

Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity

Enabling a self-organized traffic system in existing legacy hardware

The effects of protein and energy restriction on plasma transport proteins.

Potential Role of Probiotics in Ameliorating Psoriasis by Modulating Gut Microbiota in Imiquimod-Induced Psoriasis-Like Mice

The Role of Gut Microbiome in Psoriasis: Oral Administration of Staphylococcus aureus and Streptococcus danieliae Exacerbates Skin Inflammation of Imiquimod-Induced Psoriasis-Like Dermatitis

Oral and Topical Probiotics and Postbiotics in Skincare and Dermatological Therapy: A Concise Review

The Skin Microbiome and its Significance for Dermatologists

Reduced health care costs associated with disease management for chronic heart failure: a study using three methods to examine the financial impact of a heart failure disease management program among medicare advantage enrollees.